Digestive complications of aspirin (Q73672333)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10763205%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

[Digestive complications of aspirin] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10763205%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

P Hochain

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10763205%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Capet

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10763205%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Colin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10763205%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10763205%20AND%20SRC:MED&resulttype=core&format=json

Revue de Médecine Interne

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10763205%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

21 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10763205%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

50s-59s

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10763205%20AND%20SRC:MED&resulttype=core&format=json

Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

NSAID gastropathy. A new understanding

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Mechanisms for rapid re-epithelialization of the gastric mucosal surface

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Nonsteroidal Anti-Inflammatory Drugs: How Do They Damage Gastroduodenal Mucosa?

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

The hydrophobic barrier properties of gastrointestinal mucus

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Protection of human gastric mucosa against aspirin-enteric coating or dose reduction?

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Gastric adaptation: basic and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Aspirin and bleeding peptic ulcers in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Prophylactic aspirin and risk of peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Non-steroidal anti-inflammatory drugs and peptic ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Age does not influence acute aspirin-induced gastric mucosal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Gastroscopic evaluation of anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Duodenal diaphragmlike stricture induced by acetylsalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Evidence of aspirin use in both upper and lower gastrointestinal perforation

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Significant role of aspirin use in patients with esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Drug-induced oesophageal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Anti-inflammatory drugs and variceal bleeding: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Effect of aspirin on intestinal absorption of glucose, sodium, and water in man

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Proctitis and rectal stenosis induced by nonsteroidal antiinflammatory suppositories

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Anorectal stenosis in patients with prolonged use of suppositories containing paracetamol and acetylsalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Prophylaxis of aspirin-induced gastric mucosal bleeding with ranitidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

Adverse effects of low-dose aspirin in a healthy elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988725-1

7 January 2021

10.1016/S0248-8663(00)88725-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10763205%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference